Search abstracts

Standardized evaluation of TCM drug safety and its safe use in China

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Presentation
  • By: YE, Zuguang (China Academy of Chinese Medical Science, Beijing, China)
  • Abstract:

    Regulatory documents on requirements for TCM drug registration are officially issued, which are divided into 4 levels: Act, Rules, Regulation and Guidance. With the above-mentioned regulations, two-phase and two-level evaluation for TCM drug registration for marketing is established. The requirements for R & D and production of TCM drugs are


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses